249 related articles for article (PubMed ID: 31538326)
1. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
[TBL] [Abstract][Full Text] [Related]
2. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
3. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
[TBL] [Abstract][Full Text] [Related]
4. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
5. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
6. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
[TBL] [Abstract][Full Text] [Related]
7. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
[TBL] [Abstract][Full Text] [Related]
8. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
[TBL] [Abstract][Full Text] [Related]
9. Management of a full-term infant with hemolytic disease of the newborn due to an anti-Rh17 antibody in a mother with D-- phenotype.
Shah SI; Caprio M; Strauss R; Moskowitz N
Am J Hematol; 2005 Sep; 80(1):88-9. PubMed ID: 16138349
[No Abstract] [Full Text] [Related]
10. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
[TBL] [Abstract][Full Text] [Related]
11. Treatment options for the fetus with alloimmune hemolytic disease.
Bowman JM
Transfus Med Rev; 1990 Jul; 4(3):191-207. PubMed ID: 2134630
[No Abstract] [Full Text] [Related]
12. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
Trevett TN; Moise KJ
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
[TBL] [Abstract][Full Text] [Related]
13. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
[TBL] [Abstract][Full Text] [Related]
14. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
[TBL] [Abstract][Full Text] [Related]
15. Update on HDFN: new information on long-standing controversies.
Eder AF
Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion.
Bellone M; Boctor FN
Transfusion; 2014 Aug; 54(8):2118-21. PubMed ID: 24673470
[TBL] [Abstract][Full Text] [Related]
17. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
[TBL] [Abstract][Full Text] [Related]
18. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
19. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
20. Severe intrauterine hemolysis due to anti-C(w).
Chu HP; Kanagalingam D; Chan DK
Am J Perinatol; 2007 Nov; 24(10):623-6. PubMed ID: 17972235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
